Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain

Trial Profile

Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 21 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Pelvic pain
  • Focus Therapeutic Use

Most Recent Events

  • 16 May 2022 Status changed from recruiting to completed.
  • 01 Mar 2021 Status changed from not yet recruiting to recruiting as per results published in the International Journal of Gynaecology and Obstetrics
  • 01 Mar 2021 Results (N=12), published in the International Journal of Gynaecology and Obstetrics

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top